Richard Beddard

Share Sleuth: How to make the PE ratio more useful

Share Sleuth: How to make the PE ratio more useful

If making money is all you care about, all that matters in stockmarket investment is valuation. Richard Beddard explains why this simple metric is so important.

Brainjuicer shares have tripled, and could keep going

Brainjuicer shares have tripled, and could keep going

Understanding just how Brainjuicer makes money, companies analyst Richard Beddard decides it's the kind of business he likes to invest in for the long-term.

Two great companies for the Share Sleuth portfolio?

Two great companies for the Share Sleuth portfolio?

Always on the lookout for new additions to the portfolio, companies analyst Richard Beddard would 'love' to buy this share. Another could be good value.

This mid-cap dominates an oligopoly

This mid-cap dominates an oligopoly

Companies analyst Richard Beddard visited this FTSE 250 star's AGM and got close and personal with its impressive chief exec. Here's what he thought.

Share Sleuth: Why 'skin in the game' is important

Share Sleuth: Why 'skin in the game' is important

It would be good for shareholders if bosses held shares for the long term in the firms they run, says Richard Beddard.

A bargain share or certain sell?

A bargain share or certain sell?

The worst could be over for this company and the FD has some tricks up his sleeve. Analyst Richard Beddard isn't selling…yet.

Why this is the UK's best AGM

Why this is the UK's best AGM

Companies analyst Richard Beddard names the Annual General Meeting every investor should go to. It has everything, even drama!

Are these 11 shares a long-term buy?

Are these 11 shares a long-term buy?

Unable to cover every share he fancies, companies analyst Richard Beddard names the stocks that got away. He'll be investigating over the next couple of months.

A company tipped to prosper

A company tipped to prosper Victrex polymer plastic dental PEEK

It's making big money from high-tech composite material despite weakness in two key markets. Analyst Richard Beddard believes this company should deliver its ambitious goals.

Five shares for the watchlist

Five shares for the watchlist key valuations profitability sales earnings yield

Companies analyst Richard Beddard trawls through corporate results to pick great stocks for his portfolio. Here he profiles five of the most interesting candidates.

Syndicate content